Aldwych Partners advised on the competition risks associated with a planned acquisition of a major portfolio of care homes. Based on our advice, the transaction was structured to exclude those homes with the highest risk of an adverse finding by the CMA, and was subsequently cleared by the CMA at Phase 1. The parties were able to complete the transaction without any requirement for interim measures or divestment.
Puppy dogs and rainbows? M&A and competition in UK vet care
Consolidation in the UK vet sector has continued at a remarkable pace since Aldwych Partners first…Read more